Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’
Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.
Ozempic, Wegovy may lower Alzheimer’s risk in people with diabetes
Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for Alzheimer’s disease, a new study shows.
Ozempic lowers Alzheimer’s risk: Research
The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer’s disease among people with type 2 diabetes, according to a new study published Thursday. Alzheimer’s
Ozempic Can Potentially Cut Risk Of Alzheimer's Compared To Other Diabetic Medicines, Study Shows
Semaglutide, found in Novo Nordisk's Ozempic, may reduce Alzheimer's risk in type 2 diabetes patients, per new research. FDA considers banning compounded versions.
Popular diabetes, weight loss drug could reduce risk of Alzheimer's disease
A new study suggests that semaglutide, used for type 2 diabetes and weight loss under brand names like Wegovy and Ozempic, could also lower the risk of Alzheimer's disease.
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study
In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes.
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.
Medical News Today
5h
Semaglutide drugs may help keep Alzheimer's at bay
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
13h
Novo Nordisk's semaglutide could also be effective against Alzheimer's
A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...
Science Daily
8h
Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease
Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
DOJ reaches settlement
DA urges resentencing
Workers reject new contract
Grammy-winning singer dies
Funeral home owners guilty
Reporter struck by shrapnel
Florida sues Garland
LA Times editor quits
NY gun control law ruling
Hack impacted 100M people
Mailbox fire damages ballots
Kristy now Category 4
Nevada lithium mine OK’d
US charges media tycoon
Watchdog cautions firms
Sri Lanka attack alert
Hikes annual pass prices
Sued by ‘ring boys’
Nigeria releases US exec
To join Harris at rally
Sued over E. coli outbreak
CO elephants' rights case
PA provisional ballot ruling
Ohio abortion ban blocked
$135 million in Gaza aid
Unveils new AI rules
Arbery case retrial motions
Georgia citizenship audit
Data privacy violations fine
US new home sales rise
Feedback